Authorities will estimate how many excess vaccines they have on hand and discuss how to handle its mRNA shots stockpile with drug manufacturers, including postponing or canceling the delivery of certain batches, the government said in a statement.
Officials are also considering giving doses away to places that are more in need via channels like the World Health Organization's Covax as local demand for BioNTech's shots has "become sluggish," it said.
Some 840,000 doses of BioNTech's vaccines now in storage will expire in mid-August, it said, and another 1.05 million from Chinese maker Sinovac Biotech Ltd. remain unused.
Only a quarter of the daily availability of BioNTech shots are currently being administered, with some 10,000 people making bookings at community centers on a daily average, the government said, compared with a capacity of more than 40,000 doses.
The stockpile is the latest challenge facing Hong Kong's slower-than-expected vaccine rollout, which has been impeded by a lack of trust in the Beijing-backed government and concerns about rare side effects. The public's widespread reluctance to get inoculated is making the city a global outlier in the race to achieve herd immunity and be able to fully reopen.
The government has been working to encourage residents to get their shots by providing incentives like reopening bars and shortening the quarantine period for vaccinated people.
Read more: Unused Shots Pile Up as Mistrust Mars Hong Kong Vaccinations
Despite being one of a few places in the world to make vaccines available to all adults, just 12.3% of its population of 7.5 million has been fully inoculated, according to Bloomberg's Covid-19 Vaccine Tracker -- far behind other finance centers including London, at 26.3%, and Singapore, at 25.3%.
The vaccine surplus could hurt Hong Kong's chances at getting more shots going forward, Secretary for Food and Health Sophia Chan wrote in a response to a lawmaker on Wednesday.
"In the next round of procurement negotiations with the drug manufacturers, we may not be able to get an outcome as desirable as that in the present round," Chan said. "We do not know if we will be able to procure vaccine doses sufficient for the entire Hong Kong population in the next round."
Published : May 27, 2021
By : Syndication Washington Post, Bloomberg · Felix Tam